876 related articles for article (PubMed ID: 25320521)
1. Gastric cancer: prevention, screening and early diagnosis.
Pasechnikov V; Chukov S; Fedorov E; Kikuste I; Leja M
World J Gastroenterol; 2014 Oct; 20(38):13842-62. PubMed ID: 25320521
[TBL] [Abstract][Full Text] [Related]
2. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population.
Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG
Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667
[TBL] [Abstract][Full Text] [Related]
3. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
4. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
Wang X; Zhang Q; Han F; Wu Y
Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
[No Abstract] [Full Text] [Related]
5. Biopsy strategies for endoscopic screening of pre-malignant gastric lesions.
Zhang M; Liu S; Hu Y; Bao HB; Meng LN; Wang XT; Xu Y; Zhao J; Lu B
Sci Rep; 2019 Oct; 9(1):14909. PubMed ID: 31624309
[TBL] [Abstract][Full Text] [Related]
6. Gastric Cancer Screening in Common Variable Immunodeficiency.
van der Poorten DK; McLeod D; Ahlenstiel G; Read S; Kwok A; Santhakumar C; Bassan M; Culican S; Campbell D; Wong SWJ; Evans L; Jideh B; Kane A; Katelaris CH; Keat K; Ko Y; Lee JA; Limaye S; Lin MW; Murad A; Rafferty M; Suan D; Swaminathan S; Riminton SD; Toong C; Berglund LJ
J Clin Immunol; 2018 Oct; 38(7):768-777. PubMed ID: 30219982
[TBL] [Abstract][Full Text] [Related]
7. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice.
Quach DT; Hiyama T; Gotoda T
World J Gastroenterol; 2019 Jul; 25(27):3546-3562. PubMed ID: 31367156
[TBL] [Abstract][Full Text] [Related]
8. Population based Helicobacter pylori screening and eradication: advances versus side effects.
Tepes B
Curr Pharm Des; 2014; 20(28):4501-9. PubMed ID: 24180403
[TBL] [Abstract][Full Text] [Related]
9. Current issues and future perspectives of gastric cancer screening.
Hamashima C
World J Gastroenterol; 2014 Oct; 20(38):13767-74. PubMed ID: 25320514
[TBL] [Abstract][Full Text] [Related]
10. Histological Features of Gastric Mucosa Serologically Diagnosed as Gastric Atrophy without Helicobacter pylori Infection.
Okuno H; Suzuki S; Watanabe H; Kusano C; Ikehara H; Moriyama M; Gotoda T
Digestion; 2020; 101(2):217-226. PubMed ID: 30870847
[TBL] [Abstract][Full Text] [Related]
11. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.
Rugge M; Meggio A; Pravadelli C; Barbareschi M; Fassan M; Gentilini M; Zorzi M; Pretis G; Graham DY; Genta RM
Gut; 2019 Jan; 68(1):11-17. PubMed ID: 29306868
[TBL] [Abstract][Full Text] [Related]
12. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
Kowada A
Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
[TBL] [Abstract][Full Text] [Related]
13. Optimized diagnosis of
Cho JH; Jin SY
Expert Rev Gastroenterol Hepatol; 2020 Jul; 14(7):553-564. PubMed ID: 32410515
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System.
Bellolio E; Riquelme I; Riffo-Campos AL; Rueda C; Ferreccio C; Villaseca M; Brebi P; Muñoz S; Araya JC
Pathol Oncol Res; 2019 Jul; 25(3):1135-1142. PubMed ID: 30467699
[TBL] [Abstract][Full Text] [Related]
15. Gastric Cancer: Emerging Trends in Prevention, Diagnosis, and Treatment.
Norwood DA; Montalvan-Sanchez E; Dominguez RL; Morgan DR
Gastroenterol Clin North Am; 2022 Sep; 51(3):501-518. PubMed ID: 36153107
[TBL] [Abstract][Full Text] [Related]
16. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
[TBL] [Abstract][Full Text] [Related]
17. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia.
Marcos-Pinto R; Carneiro F; Dinis-Ribeiro M; Wen X; Lopes C; Figueiredo C; Machado JC; Ferreira RM; Reis CA; Ferreira J; Pedroto I; Areias J
Aliment Pharmacol Ther; 2012 Jun; 35(12):1451-9. PubMed ID: 22548492
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer prevention strategies: A global perspective.
Eusebi LH; Telese A; Marasco G; Bazzoli F; Zagari RM
J Gastroenterol Hepatol; 2020 Sep; 35(9):1495-1502. PubMed ID: 32181516
[TBL] [Abstract][Full Text] [Related]
19. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
[TBL] [Abstract][Full Text] [Related]
20. Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment.
Varbanova M; Wex T; Jechorek D; Röhl FW; Langner C; Selgrad M; Malfertheiner P
J Clin Pathol; 2016 Jan; 69(1):19-25. PubMed ID: 26163538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]